57 results
S-3
EX-4.3
RYTM
Rhythm Pharmaceuticals Inc.
2 Nov 21
Shelf registration
5:21pm
. SATISFACTION AND DISCHARGE; DEFEASANCE
Section 8.1.
Satisfaction and Discharge of Indenture
Section 8.2.
Application of Trust Funds; Indemnification … .
Satisfaction of Sinking Fund Payments with Securities
Section 11.3.
Redemption of Securities for Sinking Fund
iii
RHYTHM PHARMACEUTICALS, INC
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
capital, and for general corporate purposes. The transaction is expected to close on or about April 15, 2024, subject to the satisfaction of customary … . The Preferred Stock will vote with the common stock on an as-converted basis, subject to satisfaction of certain antitrust-related conditions.
Holders
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
of Control Period”), then, subject to your satisfaction of the Severance Conditions, the Company will, in lieu of the Severance Amount, provide severance pay … for and timely elect continued group medical plan coverage pursuant to COBRA, then, subject to the satisfaction of the Severance Conditions, the Company
10-Q
2017 Q3
EX-10.2
RYTM
Rhythm Pharmaceuticals Inc.
14 Nov 17
Quarterly report
12:00am
) any shares of Stock either delivered to or withheld by the Company in satisfaction of tax withholding obligations of the Company or an Affiliate … that would otherwise be due to such Participant by virtue of the satisfaction of any requirements or goals with respect to Performance Units. If any
8-K
EX-5.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
satisfaction, of the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws of the Company, and such other documents, records
8-K
EX-99.2
x8i2e1m19dg1g0axp
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
8-K
EX-10.2
h3d 1zfhx
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
oout3v
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
3zn403p8
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.1
l8eoks79
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
wiihr063d31pmzka
5 Feb 21
Other Events
5:27pm
8-K
mo3c7fb27sowq olpv3s
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
S-3ASR
EX-4.3
fmfhxvis88 eibh4zh
9 Nov 18
Automatic shelf registration
4:35pm
S-3ASR
EX-4.4
nhnpdxfzj8 e0sh9ime
9 Nov 18
Automatic shelf registration
4:35pm
8-K
hiudxg9brz89
15 Sep 22
Other Events
4:02pm
8-K
EX-2.1
oocpg1
5 Jan 21
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-10.1
2snq kobmn
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
8-K
EX-3.1
swygu83yut 65s
16 Apr 24
Entry into a Material Definitive Agreement
7:00am